Please login to the form below

Not currently logged in
Email:
Password:

TransCelerate

This page shows the latest TransCelerate news and features for those working in and with pharma, biotech and healthcare.

Less is more: how risk-based monitoring is changing trials

Less is more: how risk-based monitoring is changing trials

Companies wishing to take the plunge in RBM can get a leg-up thanks to work being carried out by TransCelerate, which was set up in 2012 as a collective pharma

Latest news

  • Harnessing clinical data Harnessing clinical data

    TransCelerate's initiatives. Risk-based monitoring. Shared site qualification and training. Shared investigator platform. ... While less glamorous than harnessing leading edge technologies, TransCelerate is already showing that much can be achieved

  • Think big, not small Think big, not small

    The Global Alliance for Genomics and Health is looking into improving genomic medicine through more effective data sharing, while TransCelerate BioPharma approaches R&D innovation from the perspective of those carrying

  • Biotech bounceback in 2013 only for select few Biotech bounceback in 2013 only for select few

    Examples include the TransCelerate BioPharma and Project DataSphere initiatives which are short on participation from smaller biotechs.

  • Pharma R&D costs up tenfold since 1970s Pharma R&D costs up tenfold since 1970s

    Pharma companies are also increasingly working with each other to share knowledge, including the TransCelerate BioPharma initiative involving ten of the largest firms from the US and Europe.

  • J&J, Lilly and Merck join forces on clinical trials J&J, Lilly and Merck join forces on clinical trials

    Janssen has taken a collaborative approach to other areas of the pharma R&D process, joining forces with nine other companies in September to create the TransCelerate BioPharma initiative, designed to ... Industry collaboration, including pre-competitive

More from news
Approximately 3 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Simplifying HCP access to digital information Simplifying HCP access to digital information

    Collaboration in the life science industry is not new. TransCelerate Biopharma and the Clinical Data Interchange Standards Consortium (CDISC) are examples of successful industry collaborations.

  • Avoiding data pitfalls in clinical research Avoiding data pitfalls in clinical research

    Organisations like the non-profit TransCelerate and companies like Medidata are building platforms to bring together disparate data sets from trials of similar indications to improve understanding.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Parexel strengthens clinical leadership Parexel strengthens clinical leadership

    At Accenture, he was vital in the creation of TransCelerate BioPharma, an industry group that aligns companies to address common drug development problems.

  • Merck KGaA loses global head of R&D Merck KGaA loses global head of R&D

    The company did not provide a reason for the loss of Jenkins (pictured), although she recently took up the post of chair of the board of TransCelerate BioPharma.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics